Primary Record
Virginiamycin S1
- In stock
- 6,191 g
- Purity
- 98.8 %
- CAS
- 23152-29-6
Compound Identifiers & Properties
- CAS
- 23152-29-6
- PubChem CID
- 5388936
- SMILES
- CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3CCC(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=CC=C6)C
- Canonical SMILES
- CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O
Names & Synonyms
- Virginiamycin S1
- Staphylomycin S
- Staphylomycin S1
- Virginiamycin factor S
- Virginiamycin
- Virgimycin
- Virginiamycin S
- VirginiamycinS1
- Factor S
- Staphylomycin S,
- Antibiotic 1754Z3B
- Virginiamycin factor S1
- Antibiotic 899
- Virginiamycin S-1
- Dihydrovirginiamycin S1
- Factor S [antibiotic]
- J91D5GN5AT
- UNII-J91D5GN5AT
- RefChem:194440
- 23152-29-6
- DTXSID0046856
- CHEBI:46416
- VIRGINIAMYCIN S1 [MI]
- DTXCID501021676
- orb1989708
- CHEMBL1236684
- SCHEMBL16940059
- SCHEMBL29885219
- EINECS 245-462-6
- GTPL13755
- FEPMHVLSLDOMQC-IYPFLVAKSA-N
- NSC 177858
- NSC-177858
- C43H49N7O10
- HY-N6680
- Tox21_112728
- BBF-03472
- MFCD00864857
- MSK7031-100M
- NSC177858
- ZINC94313271
- Virginiamycin S1, >=99% (HPLC)
- AKOS032945967
- MSK7031-1000M
- C43-H49-N7-O10
- CID5388936
- DB04805
- NCGC00181117-01
- E711
- CAS-23152-29-6
- J142.359B
- CS-0088760
- NS00011660
- Virginiamycin S1 100 microg/mL in Acetonitrile
- Virginiamycin S1 Solution in Methanol, 100ug/mL
- A1021259
- Q7934724
- Virginiamycin S1 Solution in Methanol, 1000ug/mL
- N-((3-Hydroxy-2-pyridinyl)carbonyl)-L-threonyl-D-alpha-aminobutyryl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenylglycine rho-lactone
- N-(3-Hydroxypicolinoyl)-L-threonyl-D-alpha-aminobutyryl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenylglycine rho-lactone
- N-[(6R,9S,10R,13S,15AS,22S,24AS)-22-BENZYL-6-ETHYL-10,23-DIMETHYL-5,8,12,15,17,21,24-HEPTAOXO-13-PHENYLDOCOSAHYDRO-12H-PYRIDO[2,1-F]PYRROLO[2,1-L][1,4,7,10,13,16]OXAPENTAAZACYCLONONADECIN-9-YL]-3-HYDROXYPYRIDINE-2-CARBOXAMIDE
- N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- 245-462-6
- GLYCINE, N-((3-HYDROXY-2-PYRIDINYL)CARBONYL)-L-THREONYL-D-2-AMINOBUTANOYL-L-PROLYL-N-METHYL-L-PHENYLALANYL-4-OXO-L-2-PIPERIDINECARBONYL-L-2-PHENYL-, .RHO.-LACTONE
- N-((3-HYDROXY-2-PYRIDINYL)CARBONYL)-L-THREONYL-D-2-AMINOBUTANOYL-L-PROLYL-N-METHYL-L-PHENYLALANYL-4-OXO-L-2-PIPERIDINECARBONYL-L-2-PHENYLGLYCINE .RHO.-LACTONE
- N-((3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo(20.4.0.06,10)hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide
- N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-pipecoloyl-L-phenyl Gly-]
- N-[(3-Hydroxy-2-pyridyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-)
- N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- Virginiamycin S1; Staphylomycin S (6CI,7CI,8CI); 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine, cyclic peptide deriv.; Antibiotic 1754Z3B; Factor S; Factor S (antibiotic); Glycine, N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-, ?-lactone; N-[(3-Hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenylglycine ?-lactone; Staphylomycin S1
- VRS